In respect of valvular AF group, 93.9% of patients used vitamin K antagonist (VKA); mean HAS-BLED score was 1.0 ± 0.9; the higher the HAS-BLED score was, the less patients used VKA. Conclusions: The proportion of using OAC in non-valvular AF population has been improved dramatically compared to that of in the past.